2009Chinese Journal of Health Laboratory TechnologyRequires access

Analysis of clinical distribution and drug-resistance of 118 strains of Acinetobacter

Shufeng Zhang

Open publisher page 0 citations

Abstract

Objective:To study the distribution and drug resistance of Acinetobacter,in a hospital,so as to provide the reference for rational use of antimicrobial agents.Methats:Acinetobacter isolated from inpatients from January,2005 to January,2009 were identified with ATB Expression microbial identification and drug sensitivity system.Results:A total of 118 strains of Acinetobacter were isolated,most Acinetobacter spp were Acinetobacter baumannii and Acinetobacter calclaceticus,the drug-resistant rate to Ampicillin/sulbactam was 80% respectivdy,drug-resistant rate to Gentamicin,tobramycin,Trimethoprim/sulifa were boty 60%;the drug-resistant rate to Piperacillin,Ticarcillin,Ciprofloxacin,Ceftazidime,Cefepime were both 40%;the drug-resistant rate to Ticarcillin/ca,Piperacillin/tazobacta,Amikacin were both30%;The drug-resistant rate to Imipenem and Meropenem were all low was 5%.Conclusion:Acinetobacter is one of the common bacteria in nosocomial infection.The drug-resistant of Acinetobacter is very serious,it is important to monitor the antimicriobial resistance of Acinetobacter.clinical doctors should use antimicriobial agents rationally and slow down the producing of drug-resistant.

About this research paper

What this paper is about

Objective:To study the distribution and drug resistance of Acinetobacter,in a hospital,so as to provide the reference for rational use of antimicrobial agents.Methats:Acinetobacter isolated from inpatients from January,2005 to January,2009 were identified with ATB Expression microbial identification and drug sensitivity system.Results:A total of 118 strains of Acinetobacter were isolated,most Acinetobacter spp were Acinetobacter baumannii and Acinetobacter calclaceticus,the drug-resistant rate to Ampicillin/sulbactam was 80% respectivdy,drug-resistant rate to Gentamicin,tobramycin,Trimethoprim/sulifa were boty 60%;the drug-resistant rate to Piperacillin,Ticarcillin,Ciprofloxacin,Ceftazidime,Cefepime were both 40%;the drug-resistant rate to Ticarcillin/ca,Piperacillin/tazobacta,Amikacin were both30%;The drug-resistant rate to Imipenem and Meropenem were all low was 5%.Conclusion:Acinetobacter is one of the common bacteria in nosocomial infection.The drug-resistant of Acinetobacter is very serious,it is important to monitor the antimicriobial resistance of Acinetobacter.clinical doctors should use antimicriobial agents rationally and slow down the producing of drug-resistant.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the distribution and drug resistance of Acinetobacter,in a hospital,so as to provide the reference for rational use of antimicrobial agents.Methats:Acinetobacter isolated from inpatients from January,2005 to January,2009 were identified with ATB Expression microbial identification and drug sensitivity system.Results:A total of 118 strains of Acinetobacter were isolated,most Acinetobacter spp were Acinetobacter baumannii and Acinetobacter calclaceticus,the drug-resistant rate to Ampicillin/sulbactam was 80% respectivdy,drug-resistant rate to Gentamicin,tobramycin,Trimethoprim/sulifa were boty 60%;the drug-resistant rate to Piperacillin,Ticarcillin,Ciprofloxacin,Ceftazidime,Cefepime were both 40%;the drug-resistant rate to Ticarcillin/ca,Piperacillin/tazobacta,Amikacin were both30%;The drug-resistant rate to Imipenem and Meropenem were all low was 5%.Conclusion:Acinetobacter is one of the common bacteria in nosocomial infection.The drug-resistant of Acinetobacter is very serious,it is important to monitor the antimicriobial resistance of Acinetobacter.clinical doctors should use antimicriobial agents rationally and slow down the producing of drug-resistant.

Key concepts: Acinetobacter, Ticarcillin, Cefepime, Piperacillin, Meropenem, Microbiology, Imipenem, Drug resistance

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis of clinical distribution and drug-resistance of 118 strains of Acinetobacter — Research Paper | ScholarLens